Company CARS HLDG OTC Bulletin Board

Equities

CGNHD

Medical Equipment, Supplies & Distribution

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Diagnostic & Testing Substances

Inactive Instrument

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2021	CardioGenics Holdings Inc. Announces License Agreement	CI
2015	CardioGenics Holdings Inc completed the acquisition of substantially all of the assets of Plasticap Inc.	CI

CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Managers	Title	Age	Since
Yahia A. Gawad FOU	Founder	66	19/11/97
James A. Essex DFI	Director of Finance/CFO	76	31/12/98
Linda J. Sterling BRD	Director/Board Member	63	31/12/00

Members of the board	Title	Age	Since
Julian Neil Tabatznik CHM	Chairman	74	31/12/02
Yahia A. Gawad FOU	Founder	66	19/11/97
Linda J. Sterling BRD	Director/Board Member	63	31/12/00
Karim Murabet BRD	Director/Board Member	66	11/01/15

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	96,050,558	93,635,283 ( 97.49 %)	0	97.49 %

Name	Equities	%	Valuation
Redwood Asset Management, Inc. 0.1822 %	175,000	0.1822 %	- $
Fife Trading, Inc. 0.000000 %	0	0.000000 %	- $

CardioGenics Holdings, Inc.

6295 Northam Drive Unit 8

L4V 1W8, Mississauga

http://www.cardiogenics.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
BIOMÉRIEUX	-6.76%	12.1B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.07%	8.14B
DIASORIN S.P.A.	+6.33%	5.72B
LANTHEUS HOLDINGS, INC.	+28.13%	5.51B
10X GENOMICS, INC.	-59.44%	2.72B
ANDON HEALTH CO., LTD.	+8.04%	2.59B
VITROLIFE AB	-8.42%	2.34B
MYRIAD GENETICS, INC.	+21.84%	2.11B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-8.15%	1.79B

Diagnostic & Testing Substances